Document Detail

Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
MedLine Citation:
PMID:  9777817     Owner:  NLM     Status:  MEDLINE    
CONTEXT: Renin profiling and age-race subgroup may help select single-drug therapy for stage 1 and stage 2 hypertension.
OBJECTIVE: To compare the plasma renin profiling and age-race subgroup methods as predictors of response to single-drug therapy in men with stage 1 and 2 hypertension as defined by the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure.
DESIGN: The Veterans Affairs Cooperative Study on Single-Drug Therapy of Hypertension, a randomized controlled trial.
SETTING: Fifteen Veterans Affairs hypertension centers.
PATIENTS: A total of 1105 ambulatory men with entry diastolic blood pressure (DBP) of 95 to 109 mm Hg, of whom 1031 had valid plasma and urine samples for renin profiling.
INTERVENTIONS: Randomization to 1 of 6 antihypertensive drugs: hydrochlorothiazide, atenolol, captopril, clonidine, diltiazem (sustained release), or prazosin.
MAIN OUTCOME MEASURE: Treatment response as assessed by percentage achieving goal DBP (<90 mm Hg) in response to a single drug that corresponded to patients' renin profile vs a single drug that corresponded to patients' age-race subgroup.
RESULTS: Clonidine and diltiazem had consistent response rates regardless of renin profile (76%, 67%, and 80% for low, medium, and high renin, respectively, for clonidine and 83%, 82%, and 83%, respectively, for diltiazem for patients with baseline DBP of 95-99 mm Hg). Hydrochlorothiazide and prazosin were best in low- and medium-renin profiles; captopril was best in medium- and high-renin profiles (low-, medium-, and high-renin response rates were 82%, 78%, and 14%, respectively, for hydrochlorothiazide; 88%, 67%, and 40%, respectively, for prazosin; and 51%, 83%, and 100%, respectively, for captopril for patients with baseline DBP of 95-99 mm Hg). Response rates for patients with baseline DBP of 95 to 99 mm Hg by age-race subgroup ranged from 70% for clonidine to 90% for prazosin for younger black men, from 50% for captopril to 97% for diltiazem for older black men, from 70% for hydrochlorothiazide to 92% for atenolol for younger white men, and from 84% for hydrochlorothiazide to 95% for diltiazem for older white men. Patients with a correct treatment for their renin profile but incorrect for age-race subgroup had a response rate of 58.7%; patients with an incorrect treatment for their renin profile but correct for age-race subgroup had a response rate of 63.1% (P = .30). After controlling for DBP and interactions with treatment group, age-race subgroup (P<.001) significantly predicted response to single-drug therapy, whereas renin profile was of borderline significance (P= .05).
CONCLUSIONS: In these men with stage 1 and stage 2 hypertension, therapeutic responses were consistent with baseline renin profile, but age-race subgroup was a better predictor of response.
R A Preston; B J Materson; D J Reda; D W Williams; R J Hamburger; W C Cushman; R J Anderson
Related Documents :
1202657 - Pyelonephritis and hypertension.
20625317 - A new-generation n/l-type calcium channel blocker leads to less activation of the renin...
7050057 - Splanchnic vasoconstriction in heat-stressed men: role of renin-angiotensin system.
8104577 - Renin suppressibility and blood pressure response during acute sodium loading in patien...
17384637 - Laser-shock compression of diamond and evidence of a negative-slope melting curve.
3946617 - Noninvasive measurements of nonlinear arterial elasticity.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  JAMA     Volume:  280     ISSN:  0098-7484     ISO Abbreviation:  JAMA     Publication Date:  1998 Oct 
Date Detail:
Created Date:  1998-10-22     Completed Date:  1998-10-22     Revised Date:  2014-09-17    
Medline Journal Info:
Nlm Unique ID:  7501160     Medline TA:  JAMA     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1168-72     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
African Continental Ancestry Group
Analysis of Variance
Antihypertensive Agents / therapeutic use*
Blood Pressure / drug effects,  physiology
Double-Blind Method
European Continental Ancestry Group
Hypertension / blood,  drug therapy*,  ethnology*
Logistic Models
Matched-Pair Analysis
Middle Aged
Renin / blood*
Treatment Outcome
Reg. No./Substance:
0/Antihypertensive Agents; EC
Comment In:
JAMA. 1999 Mar 3;281(9):793-4   [PMID:  10070992 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitt...
Next Document:  Prying open the door to the tobacco industry's secrets about nicotine: the Minnesota Tobacco Trial.